Alumis

(NASDAQ) ALMS

Current Price$25.48

Market Cap$3.32B

Since IPO (2024)+96%

5 YearN/A

1 Year+494%

1 Month+12%

Alumis Financials at a Glance

Market Cap

$3.32B

Revenue (TTM)

$24.05M

Net Income (TTM)

$243.32M

EPS (TTM)

$-3.00

P/E Ratio

-8.71

Dividend

$0.00

Beta (Volatility)

0.90 (Low)

Dividend

$0.00

Beta (Volatility)

0.90 (Low)

Price

$25.48

Volume

11,490

Open

$26.06

Price

$25.48

Volume

11,490

Open

$26.06

Previous Close

$25.48

Daily Range

$25.46 - $26.09

52-Week Range

$2.76 - $30.60

Dividend

$0.00

Beta (Volatility)

0.90 (Low)

Price

$25.48

Volume

11,490

Open

$26.06

Previous Close

$25.48

Daily Range

$25.46 - $26.09

52-Week Range

$2.76 - $30.60

ALMS News

Alumis Stock Has Rallied 250% This Past Year. One Fund Sold Its $5 Million Stake Last Quarter.

Jonathan PoncianoFeb 3, 2026

An Almus (ALMS) Insider Bought 588,000 Shares for $10.0 Million

Cory RenauerJan 17, 2026

Stock Market Today, Jan. 6: Alumis Shares Surge on Positive Phase 3 Psoriasis Data for Envudeucitinib

Howard SmithJan 6, 2026

Alumis Misses Q2 Revenue as Costs Jump

Motley Fool Markets TeamAug 13, 2025

ALMS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Alumis

Industry

Pharmaceuticals

Sector

Health Care

Employees

224

CEO

Martin Babler

Website

www.alumis.com

Headquarters

South San Francisco, CA 94080, US

ALMS Financials

Key Financial Metrics (TTM)

Gross Margin

96%

Operating Margin

-18%

Net Income Margin

-10%

Return on Equity

-87%

Return on Capital

-1%

Return on Assets

-59%

Earnings Yield

-11.48%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.32B

Shares Outstanding

127.20M

Volume

11.49K

Avg. Volume

1.42M

Financials (TTM)

Gross Profit

$20.55M

Operating Income

$427.20M

EBITDA

$423.71M

Operating Cash Flow

$369.52M

Capital Expenditure

$653.00K

Free Cash Flow

$370.18M

Cash & ST Invst.

$308.50M

Total Debt

$36.91M

Alumis Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$1.93M

N/A

Gross Profit

$1.06M

+229.5%

Gross Margin

55.05%

N/A

Market Cap

$3.32B

N/A

Market Cap/Employee

$19.78M

N/A

Employees

168

N/A

Net Income

$92.93M

+1.9%

EBITDA

$83.68M

+10.9%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$271.59M

+5.5%

Accounts Receivable

$2.08M

+15.0%

Inventory

$0.00

N/A

Long Term Debt

$32.24M

+10.6%

Short Term Debt

$4.67M

+199.9%

Return on Assets

-59.07%

N/A

Return on Invested Capital

-1.31%

N/A

Free Cash Flow

$71.91M

+4.3%

Operating Cash Flow

$71.91M

+3.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

OMEROmeros Corporation

OMEROmeros Corporation$14.83+0.41%

RAPTRAPT Therapeutics, Inc.

RAPTRAPT Therapeutics, Inc.$58.01+0.00%

ETONEton Pharmaceuticals, Inc.

ETONEton Pharmaceuticals, Inc.$30.15-0.76%

LXRXLexicon Pharmaceuticals, Inc.

LXRXLexicon Pharmaceuticals, Inc.$1.60-3.03%

OCGNOcugen, Inc.

OCGNOcugen, Inc.$1.46-2.35%

ADCTADC Therapeutics S.A.

ADCTADC Therapeutics S.A.$3.86+2.66%

NMRANeumora Therapeutics, Inc. Common Stock

NMRANeumora Therapeutics, Inc. Common Stock$2.33+1.30%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$113.01+0.04%

NOKNokia

NOKNokia$13.19-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.14-0.12%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.58+0.05%

CTRACoterra Energy

CTRACoterra Energy$32.56-0.09%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.57+0.06%

POETPoet Technologies

POETPoet Technologies$9.72+0.06%

Questions About ALMS

What is the current price of Alumis?

Alumis is trading at $25.48 per share.

What is the 52-week range for Alumis?

Over the past 52 weeks, Alumis has traded between $2.76 and $30.60.

How much debt does Alumis have?

As of the most recent reporting period, Alumis reported total debt of $36.91M.

How much cash does Alumis have on hand?

Alumis reported $89.75M in cash and cash equivalents in its most recent financial results.

What is Alumis’s dividend yield?

Alumis does not currently have a dividend yield.

Alumis

Alumis Financials at a Glance

ALMS News

Alumis Stock Has Rallied 250% This Past Year. One Fund Sold Its $5 Million Stake Last Quarter.

An Almus (ALMS) Insider Bought 588,000 Shares for $10.0 Million

Stock Market Today, Jan. 6: Alumis Shares Surge on Positive Phase 3 Psoriasis Data for Envudeucitinib

Alumis Misses Q2 Revenue as Costs Jump

ALMS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Alumis

ALMS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Alumis Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ALMS

What is the current price of Alumis?

What is the 52-week range for Alumis?

How much debt does Alumis have?

How much cash does Alumis have on hand?

What is Alumis’s dividend yield?

Premium Investing Services